NCT00004729
- Conditions
- Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
- Locations
-
- Johns Hopkins Hospital Baltimore, Maryland, United States
Clinical trial condition
Epileptic Syndromes
Explore clinical trials studying Epileptic Syndromes. Study availability and eligibility vary by location and protocol.
201 public trials
44 recruiting studies
Epileptic Syndromes trial results
NCT00004776
- Conditions
- Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
- Locations
-
Not specified
NCT00004758
- Conditions
- Brain Diseases, Central Nervous System Diseases, Disease Attributes, +12 more
- Locations
-
Not specified
Active, Not Recruiting
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
NCT05044819
- Conditions
- Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +27 more
- Locations
-
- Clinical Trial Site Little Rock, Arkansas, United States
- Clinical Trial Site Downey, California, United States
- Clinical Trial Site Long Beach, California, United States
- Clinical Trial Site Sacramento, California, United States
Active, Not Recruiting
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)
NCT06719141
- Conditions
- Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
- Locations
-
- Arkansas Children's Hospital - PIN Little Rock, Arkansas, United States
- Children's Hospital Los Angeles - PIN Los Angeles, California, United States
- David Geffen School of Medicine at UCLA Los Angeles, California, United States
- The Stanford Division of Child Neurology Palo Alto, California, United States
Active, Not Recruiting
A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
NCT06315322
- Conditions
- Brain Diseases, Central Nervous System Diseases, Childhood Absence Epilepsy, +6 more
- Locations
-
- Ep0224 50140 Birmingham, Alabama, United States
- Ep0224 50639 Orange, California, United States
- Ep0224 50268 Miami, Florida, United States
- Ep0224 50638 New Brunswick, New Jersey, United States
Active, Not Recruiting
Personalized Antisense Oligonucleotide for A Single Participant With ATN1 Gene Mutation
NCT07084311
- Conditions
- Brain Diseases, Central Nervous System Diseases, Dentatorubral-Pallidoluysian Atrophy, +6 more
- Locations
-
- Hawaii Pacific Neuroscience Honolulu, Hawaii, United States
Active, Not Recruiting
Early Check: Expanded Screening in Newborns
NCT03655223
- Conditions
- 17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
- Locations
-
- RTI International Research Triangle Park, North Carolina, United States
Active, Not Recruiting
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome
NCT06118255
- Conditions
- Brain Diseases, Central Nervous System Diseases, Dravet Syndrome, +5 more
- Locations
-
- Ep0213 105 Memphis, Tennessee, United States
- Ep0213 107 Dallas, Texas, United States
- Ep0213 103 Seattle, Washington, United States
- Ep0213 502 Brussels, Belgium
Active, Not Recruiting
A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome
NCT06283212
- Conditions
- Brain Diseases, Central Nervous System Diseases, Dravet Syndrome, +5 more
- Locations
-
- Queen Elizabeth Hospital Glasgow, United Kingdom
- Great Ormond Street Hospital London, United Kingdom
- Sheffield Children's Hospital Sheffield, United Kingdom